Fortuanto et al developed a discriminant function using 6 biochemical markers that can be used to separate patients with chronic hepatitis from those with cirrhosis. This can help monitor patients with progressive disease and can help guide use of more expensive or invasive tests. The authors are from the Universita di Napoli and Universita del Molise in Italy